Significance of pH regulation and carbonic anhydrases in tumour progression and implications for diagnostic and therapeutic approaches

BJU International, Supplement

Volumn 101, Issue SUPPL.4, 2008, Pages 16-21

  Parkkila, Seppo ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE III; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; TUMOR PROTEIN;

CELL PH; CYTOSOL; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RNA SEQUENCE; SOLID TUMOR; TUMOR GROWTH; DISEASE COURSE; ENZYMOLOGY; METABOLISM; NEOPLASM; PH;

CARBONIC ANHYDRASES; DISEASE PROGRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS;

EID: 44449176131     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995; 64: 375-401
2. Parkkila S, Parkkila AK. Carbonic anhydrase in the alimentary tract. Roles of the different isozymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal. Scand J Gastroenterol 1996; 31: 305-317 (Pubitemid 26117752)
3. Lehtonen J, Shen B, Vihinen M et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004; 279: 2719-2727 (Pubitemid 38114261)
4. Hilvo M, Tolvanen M, Clark A et al. Characterization of CA XV, a new GPIanchored form of carbonic anhydrase. Biochem J 2005; 392: 83-92 (Pubitemid 41689404)
5. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004; 19: 199-229 (Pubitemid 39004275)
6. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J Med Chem 2005; 48: 7860-7866 (Pubitemid 41698823)
7. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg Med Chem Lett 2005; 15: 3828-3833 (Pubitemid 41095477)
8. Whittington DA, Grubb JH, Waheed A, Shah GN, Sly WS, Christiansen DW. Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: implications for selective inhibition of membrane-associated isozymes. J Biol Chem 2004; 279: 7223-7228 (Pubitemid 38248870)
9. Ulmasov B, Waheed A, Shah GN et al. Purification and kinetic analysis of recombinant CAXII, a membrane carbonic anhydrase overexpressed in certain cancers. Proc Natl Acad Sci USA 2000; 97: 14212-14217 (Pubitemid 32016556)
10. Karhumaa P, Parkkila S, Waheed A et al. Nuclear NonO/p54(nrb) protein is a nonclassical carbonic anhydrase. J Biol Chem 2000; 275: 16044-16049 (Pubitemid 30366911)
11. Tashian RE, Hewett-Emmett D, Carter N, Bergenhem NC. Carbonic anhydrase (CA)-related proteins (CA-RPs), and transmembrane proteins with CA or CA-RP domains. EXS 2000; 90: 105-120
12. Thiry A, Dogne JM, Supuran CT, Masereel B. Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem 2007; 7: 855-864 (Pubitemid 46825082)
13. Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Top Med Chem 2007; 7: 849-854 (Pubitemid 46825081)
14. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007; 15: 4336-4350 (Pubitemid 46777288)
15. Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 2006; 4: 61-70
16. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996; 56: 1194-1198 (Pubitemid 26080953)
17. Pastorekova S, Parkkila S, Zavada J. Tumor-associated carbonic anhydrases and their clinical significance. Adv Clin Chem 2006; 42: 167-216 (Pubitemid 44302109)
18. Martinez-Zaguilan R, Seftor EA Seftor RE, Chu YW, Gillies RJ, Hendrix MJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 1996; 14: 176-186 (Pubitemid 26074280)
19. Raghunand N, Gatenby RA, Gillies RJ. Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 2003; 76: S11-22 (Pubitemid 39530312)
20. Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 1993; 13:1549-1556
21. Newell K, Franchi A, Pouyssegur J, Tannock I. Studies with glycolysisdeficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc Natl Acad Sci USA 1993; 90: 1127-1131 (Pubitemid 23053964)
22. Yamagata M, Hasuda K, Stamato T, Tannock IF. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 1998; 77: 1726-1731 (Pubitemid 28254604)
23. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res 2002; 8: 1284-1291 (Pubitemid 35177386)
24. Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007; 26: 299-310
25. Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 2004; 64: 6160-6165 (Pubitemid 39129417)
26. Gramlich TL, Hennigar RA, Spicer SS, Schulte BA. Immunohistochemical localization of sodium-potassiumstimulated adenosine triphosphatase and carbonic anhydrase in human colon and colonic neoplasms. Arch Pathol Lab Med 1990; 114: 415-419
27. Kummola L, Hamalainen JM, Kivela J et al. Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer 2005; 5: 41 (Pubitemid 41461088)
28. Niemela AM, Hynninen P, Mecklin JP et al. Carbonic anhydrase IX is highly expressed in hereditary nonpolyposis colorectal cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1760-1766 (Pubitemid 47450505)
29. Parkkila S, Parkkila AK, Juvonen T, Lehto VP, Rajaniemi H. Immunohistochemical demonstration of the carbonic anhydrase isozyme I and II in pancreatic tumours. Histochem J 1995; 27: 133-138
30. Leppilampi M, Koistinen P, Savolainen ER et al. The expression of carbonic anhydrase II in hematological malignancies. Clin Cancer Res 2002; 8: 2240-2245 (Pubitemid 34753596)
31. Parkkila AK, Herva R, Parkkila S, Rajaniemi H. Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours. Histochem J 1995; 27: 974-982 (Pubitemid 26040130)
32. Haapasalo J, Nordfors K, Jarvela S et al. Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. Neuro Oncol 2007; 9: 308-313 (Pubitemid 47169663)
33. Yoshiura K, Nakaoka T, Nishishita T et al. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res 2005; 11: 8201-8207 (Pubitemid 41698765)
34. Pastorekova S, Parkkila S, Parkkila AK et al. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997; 112: 398-408 (Pubitemid 27078826)
35. Saarnio J, Parkkila S, Parkkila AK et al. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarised expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem 1998; 46:,497-504 (Pubitemid 28158469)
36. Saarnio J, Parkkila S, Parkkila AK et al. Transmembrane carbonic anhydrase, MN/ CA IX, is a potential biomarker for biliary tumours. J Hepatol 2001; 35: 643-649 (Pubitemid 33078275)
37. Kivela AJ, Parkkila S, Saarnio J et al. Expression of transmembrane carbonic anhydrase isozyme IX and XII in normal human pancreas and pancreatic tumours. Histochem Cell Biol 2000; 114: 197-204 (Pubitemid 30764024)
38. Karhumaa P, Kaunisto K, Parkkila S et al. Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts. Mol Hum Reprod 2001 ; 7: 611-616 (Pubitemid 32633409)
39. Ivanov S, Liao SY, Ivanova A et al. Expression of hypoxia-inducible cellsurface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001; 158: 905-919 (Pubitemid 32221783)
40. Wingo T, Tu C, Laipis PJ, Silverman DN. The catalytic properties of human carbonic anhydrase IX. Biochem Biophys Res Commun 2001; 288: 666-669 (Pubitemid 33030081)
41. Vullo D, Franchi M, Gallon E et al. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2003; 13: 10059
42. Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Lett 2004; 14:869-873 (Pubitemid 38167605)
43. Ivanov SV, Kuzmin I, Wei MH et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 1998; 95: 12596-12601 (Pubitemid 28483810)
44. Svastova E, Hulikova A, Rafajova M et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004; 577: 439-445 (Pubitemid 39535327)
45. Sterling D, Alvarez BV, Casey JR. The extracellular component of a transport metabolon. Extracellular loop 4 of the human AE1 CI-/HC03-exchanger binds carbonic anhydrase IV. J Biol Chem 2002; 277: 25239-25246 (Pubitemid 34951831)
46. Morgan PE, Pastorekova S, StuartTilley AK, Alper SL, Casey JR. Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. Am J Physiol Cell Physiol 2007; 293: C738-48 (Pubitemid 47235179)
47. Saarnio J, Parkkila S, Parkkila AK et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 1998; 153: 279-285 (Pubitemid 28317531)
48. Turner JR, Odze RD, Crum CP, Resnick MB. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. Hum Pathol 1997; 28: 740-744
49. Leppilampi M, Saarnio J, Karttunen TJ et al. Carbonic anhydrase isozymes IX and XII in gastric tumors. World J Gastroenterol 2003; 9: 1398-1403 (Pubitemid 36992321)
50. Chen J, Rocken C, Hoffmann J et al. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut 2005; 54: 920-927 (Pubitemid 40873901)
51. Haapasalo JA, Nordfors KM, Hilvo M et al. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 2006; 12: 4737
52. Kim SJ, Rabbani ZN, Vollmer RT et al. Carbonic anhydrase IX in early-stage nonsmall cell lung cancer. Clin Cancer Res 2004; 10: 7925-7933 (Pubitemid 39587532)
53. Kim SJ, Rabbani ZN, Dewhirst MW et al. Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 2005; 49: 325-335 (Pubitemid 41139145)
54. Giatromanolaki A, Koukourakis Ml, Sivridis E et al. Expression of hypoxiainducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001 ; 61: 7992-7998 (Pubitemid 33049392)
55. Maseide K, Kandel RA, Bell RS et al. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma. Clin Cancer Res 2004; 10: 4464-4471 (Pubitemid 38878890)
56. Liao SY, Brewer C, Zavada J et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994; 145: 598-609 (Pubitemid 24285967)
57. Loncaster JA, Harris AL, Davidson SE et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001 ; 61: 63949
58. Bartosova M, Parkkila S, Pohlodek K et al. Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J Pathol 2002; 197: 314-321 (Pubitemid 34778301)
59. Brennan DJ, Jirstrom K, Kronblad A et al. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006; 12: 6421-6431 (Pubitemid 44799714)
60. Hussain SA, Ganesan R, Reynolds G et al. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer 2007; 96: 104-109 (Pubitemid 46094646)
61. Chia SK, Wykoff CC, Watson PH et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001 ; 19: 3660-3668
62. Span PN, Bussink J, De Mulder PH, Sweep FC. Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer. Br J Cancer 2007; 96: 1309-1310
63. Beasley NJ, Wykoff CC, Watson PH et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 2001; 61: 5262-5267
64. De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R, Nuyts S. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy+/chemotherapy. BMC Cancer 2005; 5: 42 (Pubitemid 41461087)
65. Le QT, Kong C, Lavori PW et al. Expression and prognostic significance of a panel of tissue hypoxia markers in headand-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2007; 69: 167-175
66. Hoogsteen IJ, Marres HA, Bussink J, van der Kogel AJ, Kaanders JH. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck 2007; 29: 591-604 (Pubitemid 47324777)
67. McKiernan JM, Buttyan R, Bander NH et al. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res 1997;57:2362-2365 (Pubitemid 27255890)
68. Parkkila S, Parkkila AK, Saarnio J et al. Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J Histochem Cytochem 2000; 48: 1601-1608
69. Sandlund J, Oosterwijk E, Grankvist K, Oosterwijk-Wakka J, Ljungberg B, Rasmuson T. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma. BJU Int 2007; 100: 556-560 (Pubitemid 47205465)
70. Bleumer I, Oosterwijk E, OosterwijkWakka JC et al. A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma. J Urol 2006; 175: 57-62 (Pubitemid 41797084)
71. Kivela A, Parkkila S, Saarnio J et al. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol 2000; 156: 577-584 (Pubitemid 30643813)
72. Haapasalo J, Hilvo M, Nordfors K et al. Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas. Neuro Oncol 2008 (in press)
73. Watson PH, Chia SK, Wykoff CC et al. Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer 2003; 88: 1065-1070
74. Kim JY, Shin HJ, Kim TH et al. Tumorassociated carbonic anhydrases are linked to metastases in primary cervical cancer. J Cancer Res Clin Oncol 2006; 132: 302-308